We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-20.39%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$26.1B
AUM Growth
-$17B
(-39%)
Cap. Flow
-$7.43B
Cap. Flow
% of AUM
-28.45%
Top 10 Holdings %
Top 10 Hldgs %
12.41%
Holding
2,672
New
335
Increased
1,090
Reduced
994
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$359M |
| 2 |
Microsoft
MSFT
|
+$330M |
| 3 |
Coca-Cola
KO
|
+$284M |
| 4 |
JPMorgan Chase
JPM
|
+$256M |
| 5 |
Verizon
VZ
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$392M |
| 2 |
Meta Platforms (Facebook)
META
|
+$331M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$325M |
| 4 |
Cisco
CSCO
|
+$325M |
| 5 |
McDonald's
MCD
|
+$318M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.33% |
| 2 | Healthcare | 16.64% |
| 3 | Consumer Discretionary | 11.59% |
| 4 | Financials | 11.58% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENZ
2151
DELISTED
Enzo Biochem, Inc.
ENZ
| $210K | ﹤0.01% |
82,957
-21,100
| -20% | -$51.8K |
|
|
NETI
2152
DELISTED
Eneti Inc.
NETI
| $210K | ﹤0.01% |
+8,300
| New | +$307K |
|
2153
Akebia Therapeutics
AKBA
$362M
| $209K | ﹤0.01% |
+27,606
| New | +$215K |
|
2154
Johnson Controls International
JCI
$87.8B
| $208K | ﹤0.01% |
+7,700
| New | +$287K |
|
2155
Merchants Bancorp
MBIN
$2.55B
| $208K | ﹤0.01% |
20,550
-13,800
| -40% | -$169K |
|
|
ONCY
2156
Oncolytics Biotech
ONCY
$89.9M
| $208K | ﹤0.01% |
+150,700
| New | +$376K |
|
2157
RCI Hospitality Holdings
RICK
$197M
| $207K | ﹤0.01% |
20,800
+1,400
| +7% | +$24.9K |
|
2158
SmartFinancial
SMBK
$900M
| $207K | ﹤0.01% |
13,600
-500
| -4% | -$9.82K |
|
|
OYST
2159
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $207K | ﹤0.01% |
+5,900
| New | +$191K |
|
2160
Microchip Technology
MCHP
$40.7B
| $206K | ﹤0.01% |
6,074
-50,352
| -89% | -$2.37M |
|
|
KG
2161
Kestrel Group
KG
$67.1M
| $206K | ﹤0.01% |
11,302
-4,455
| -28% | -$75.8K |
|
2162
Solid Biosciences
SLDB
$836M
| $206K | ﹤0.01% |
5,747
+4,894
| +574% | +$242K |
|
2163
Alaunos Therapeutics
TCRT
$4.59M
| $205K | ﹤0.01% |
+559
| New | +$289K |
|
2164
Veru
VERU
$35.6M
| $205K | ﹤0.01% |
+6,270
| New | +$235K |
|
|
TGI
2165
DELISTED
Triumph Group
TGI
| $204K | ﹤0.01% |
30,200
+900
| +3% | +$16.4K |
|
2166
Iridium Communications
IRDM
$5.05B
| $203K | ﹤0.01% |
9,100
-300
| -3% | -$7.77K |
|
2167
National Bank Holdings
NBHC
$1.9B
| $203K | ﹤0.01% |
+8,500
| New | +$265K |
|
|
CADE
2168
DELISTED
Cadence Bank
CADE
| $202K | ﹤0.01% |
+10,700
| New | +$283K |
|
2169
Commerce Bancshares
CBSH
$8.55B
| $202K | ﹤0.01% |
+5,367
| New | +$254K |
|
2170
Acacia Research
ACTG
$426M
| $200K | ﹤0.01% |
90,015
-2,900
| -3% | -$7.08K |
|
2171
Cerus
CERS
$579M
| $199K | ﹤0.01% |
42,700
-13,700
| -24% | -$62K |
|
|
SRGA
2172
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $199K | ﹤0.01% |
3,879
-274
| -7% | -$28.6K |
|
2173
KALA BIO
KALA
$13.6M
| $198K | ﹤0.01% |
+9
| New | +$144K |
|
2174
Harvard Bioscience
HBIO
$27.5M
| $197K | ﹤0.01% |
8,936
-1,320
| -13% | -$35.8K |
|
|
BELFB
2175
Bel Fuse Inc Class B
BELFB
$3.6B
| $194K | ﹤0.01% |
19,915
+2,200
| +12% | +$32K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2020 Portfolio in Review
As of Q1 2020, Two Sigma Advisers held 2,672 positions worth $26.1B, down 39% from $43.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Two Sigma Advisers withdrew a net $7.43B in Q1 2020, closing 232 positions and reducing 994 holdings. Its most notable exit was Baidu, an estimated $83.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Advisers opened a new position in Berkshire Hathaway Class B worth $147M.
- Two Sigma Advisers's largest Q1 2020 buy was Berkshire Hathaway Class B: 804,100 shares worth $147M.
- Two Sigma Advisers added most to Apple in Q1 2020, an estimated $359M increase.
- Two Sigma Advisers's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $392M.
- Two Sigma Advisers fully exited Baidu in Q1 2020, selling an estimated $83.4M.
- Two Sigma Advisers's ten largest holdings make up 12% of its $26.1B portfolio in Q1 2020.
- Two Sigma Advisers opened 335 new positions and closed 232 in Q1 2020.
- Two Sigma Advisers's portfolio value fell 39% quarter-over-quarter to $26.1B.
Based on Two Sigma Advisers's 13F filing for Q1 2020, filed 15 May 2020.